Greenlight Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-700,000
Closed -$22.4M 44
2022
Q2
$22.4M Sell
700,000
-1,441,814
-67% -$53M 1.74% 16
2022
Q1
$67.4M Buy
2,141,814
+400,000
+23% +$12.5M 4.28% 7
2021
Q4
$58.5M Sell
1,741,814
-580,605
-25% -$18.1M 3.34% 8
2021
Q3
$67.5M Sell
2,322,419
-9,160
-0.4% -$297K 4.53% 6
2021
Q2
$81.1M Buy
2,331,579
+100,000
+4% +$3.31M 5.09% 5
2021
Q1
$62.3M Sell
2,231,579
-365,670
-14% -$9.73M 4.34% 7
2020
Q4
$64.4M Sell
2,597,249
-449,700
-15% -$10.7M 3.87% 7
2020
Q3
$63.7M Sell
3,046,949
-349,000
-10% -$6.73M 5.2% 7
2020
Q2
$52.1M Sell
3,395,949
-1,487,600
-30% -$18.8M 5.65% 7
2020
Q1
$43.3M Sell
4,883,549
-1,927,194
-28% -$27.8M 6.17% 5
2019
Q4
$123M Buy
6,810,743
+327,402
+5% +$5.44M 9.14% 5
2019
Q3
$96.9M Buy
6,483,341
+2,761,518
+74% +$44.9M 6.97% 5
2019
Q2
$89.3M Buy
+3,721,823
New +$110M 6.59% 6
2019
Q1
Sell
-200,000
Closed -$5.64M 19
2018
Q4
$5.64M Buy
+200,000
New +$6.33M 0.41% 19
2018
Q1
Sell
-1,048,100
Closed -$52.5M 37
2017
Q4
$52.5M Sell
1,048,100
-436,900
-29% -$22.9M 0.95% 20
2017
Q3
$75.2M Sell
1,485,000
-2,118,070
-59% -$99.9M 1.2% 21
2017
Q2
$137M Sell
3,603,070
-1,396,930
-28% -$55.1M 2.2% 13
2017
Q1
$193M Sell
5,000,000
-3,945,144
-44% -$119M 2.68% 11
2016
Q4
$198M Sell
8,945,144
-7,422,042
-45% -$152M 3.4% 10
2016
Q3
$262M Sell
16,367,186
-42,700
-0.3% -$488K 5.01% 6
2016
Q2
$135M Buy
16,409,886
+7,567,286
+86% +$67.4M 2.48% 12
2016
Q1
$61.9M Buy
8,842,600
+5,442,600
+160% +$27.3M 1.05% 26
2015
Q4
$18.2M Buy
+3,400,000
New +$21.7M 0.33% 40

Other funds holding CC

Greenlight Capital's CC Position: Q3 2022 in Review

Greenlight Capital sold out of Chemours (CC) in Q3 2022, closing a stake of 700,000 shares — an estimated $22.4M sold.

Greenlight Capital first reported a position in CC in Q4 2015 and held it in 23 quarters. The position peaked at $262M in Q3 2016. 487 funds tracked by Wall St. Rank hold CC as of Q3 2022.

  • Greenlight Capital reported no remaining Chemours position as of Q3 2022 after selling out during the quarter.
  • Greenlight Capital sold 700,000 Chemours shares in Q3 2022, an estimated $22.4M.
  • Greenlight Capital first reported a position in Chemours in Q4 2015 and held it in 23 quarters.
  • Greenlight Capital's Chemours position peaked at $262M in Q3 2016.
  • 487 funds tracked by Wall St. Rank held Chemours as of Q3 2022.

Based on Greenlight Capital's 13F filing for Q3 2022, filed 14 Nov 2022.